131 related articles for article (PubMed ID: 11761820)
1. [The effect of specific immunotherapy on serum eotaxin level in patients with pollinosis: preliminary studies].
Jahnz-Rózyk K; Głodzińska-Wyszogrodzka E; Rozyńska-Polańska R; Paluchowska E; Zabielski LS
Pol Merkur Lekarski; 2001 Sep; 11(63):244-6. PubMed ID: 11761820
[TBL] [Abstract][Full Text] [Related]
2. A follow-up study of immunotherapy-treated birch-allergic patients: effect on the expression of chemokines in the nasal mucosa.
Plewako H; Holmberg K; Oancea I; Gotlib T; Samoliński B; Rak S
Clin Exp Allergy; 2008 Jul; 38(7):1124-31. PubMed ID: 18691293
[TBL] [Abstract][Full Text] [Related]
3. Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.
Jahnz-Rózyk K; Targowski T; Głodzinska-Wyszogrodzka E; Płusa T
Allergy; 2003 Jul; 58(7):595-601. PubMed ID: 12823117
[TBL] [Abstract][Full Text] [Related]
4. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
Alonso R; Enrique E; Pineda F; Basagaña M; San Miguel-Moncín MM; Bartra J; Palacios R; Cisteró-Bahíma A
Int Arch Allergy Immunol; 2007; 143(3):185-9. PubMed ID: 17284927
[TBL] [Abstract][Full Text] [Related]
5. Influence of age and gender on serum eotaxin concentration in healthy and allergic people.
Targowski T; Jahnz-Rózyk K; Plusa T; Glodzinska-Wyszogrodzka E
J Investig Allergol Clin Immunol; 2005; 15(4):277-82. PubMed ID: 16433209
[TBL] [Abstract][Full Text] [Related]
6. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
Rak S; Heinrich C; Scheynius A
Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
8. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
[TBL] [Abstract][Full Text] [Related]
9. Does specific immunotherapy injection cause an increase in bronchial reactivity?
Keskin O; Tuncer A; Yildirim S; Bursali B; Adalioglu G; Sekerel BE
J Asthma; 2005 Nov; 42(9):765-8. PubMed ID: 16316871
[TBL] [Abstract][Full Text] [Related]
10. Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function.
Jahnz-Ró yk K; Plusa T; Mierzejewska J
Mediators Inflamm; 2000; 9(3-4):175-9. PubMed ID: 11132775
[TBL] [Abstract][Full Text] [Related]
11. Food allergy to apple and specific immunotherapy with birch pollen.
Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
[TBL] [Abstract][Full Text] [Related]
12. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
13. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B
Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J
Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911
[TBL] [Abstract][Full Text] [Related]
15. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2006 Nov; 24(47-48):6990-3. PubMed ID: 17011086
[TBL] [Abstract][Full Text] [Related]
16. Seasonal changes of proapoptotic soluble Fas ligand level in allergic rhinitis combined with asthma.
Mezei G; Lévay M; Sepler Z; Héninger E; Kozma GT; Cserháti E
Pediatr Allergy Immunol; 2006 Sep; 17(6):444-9. PubMed ID: 16925690
[TBL] [Abstract][Full Text] [Related]
17. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.
Leonardi A; Jose PJ; Zhan H; Calder VL
Ophthalmology; 2003 Mar; 110(3):487-92. PubMed ID: 12623809
[TBL] [Abstract][Full Text] [Related]
18. [The influence of a three-year preseasonal specific immunotherapy on selected parameters of allergic inflammation in pollinosis patients].
Fal AM; Gietkiewicz K; Obojski A; Medrala W; Małolepszy J
Pneumonol Alergol Pol; 2002; 70(1-2):78-86. PubMed ID: 12148181
[TBL] [Abstract][Full Text] [Related]
19. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
[TBL] [Abstract][Full Text] [Related]
20. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
